The complexity of interactions between lipid subfractions presents a challenge to clinicians in terms of risk assessment and treatment planning, as well as patient education. Growing recognition of the importance of subfractions beyond low-density lipoprotein cholesterol in the development of atherosclerosis and coronary artery disease underscores the need to target therapy toward specific lipid abnormalities and has led to renewed appreciation for niacin as a lipid-modifying agent.
|Original language||English (US)|
|Number of pages||3|
|Journal||American Journal of Cardiology|
|State||Published - Feb 15 1998|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine